Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 124,609 | 121,797 | 138,255 | 134,521 | 130,159 |
| Cost of Goods | 101,371 | 102,073 | 109,516 | 104,901 | 103,701 |
| Gross Profit | 23,238 | 19,724 | 28,739 | 29,620 | 26,458 |
| Operating Expenses | 14,458 | 17,910 | 13,423 | 9,593 | 11,868 |
| Operating Income | 9,151 | 1,887 | 15,832 | 20,928 | 15,291 |
| Interest Expense | 2,846 | 2,891 | 2,609 | 2,650 | 2,711 |
| Pre-tax Income | 6,305 | -1,004 | 13,223 | 18,278 | 12,580 |
| Income Tax | 507 | -251 | 8,094 | 3,754 | 1,911 |
| Net Income Continuous | 5,798 | -753 | 5,129 | 14,524 | 10,669 |
| Minority Interests | -158 | 36 | 181 | 285 | 33 |
| Net Income | $5,956 | $-789 | $4,948 | $14,239 | $10,636 |
| EPS Basic Total Ops | 0.13 | -0.02 | 0.10 | 0.31 | 0.23 |
| EPS Basic Continuous Ops | 0.13 | -0.02 | 0.11 | 0.31 | 0.23 |
| EPS Diluted Total Ops | 0.12 | -0.02 | 0.10 | 0.30 | 0.23 |
| EPS Diluted Continuous Ops | 0.12 | -0.02 | 0.11 | 0.31 | 0.23 |
| EPS Diluted Before Non-Recurring Items | 0.11 | 0.06 | 0.21 | 0.22 | 0.19 |
| EBITDA(a) | $12,976 | $5,651 | $19,500 | $24,522 | $18,961 |